ArticleCancer reports (Hoboken, N.J.)2022

A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer.

Bryan C Szeglin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.